{"id":"https://openalex.org/W133168192","doi":null,"title":"[Effective therapeutic regimens for patients with triple-negative (ER/PgR/HER2-negative) metastatic breast cancer].","display_name":"[Effective therapeutic regimens for patients with triple-negative (ER/PgR/HER2-negative) metastatic breast cancer].","publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W133168192","mag":"133168192","pmid":"https://pubmed.ncbi.nlm.nih.gov/20647706"},"language":"ja","primary_location":{"id":"pmid:20647706","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20647706","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079803799","display_name":"Norimichi Kan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norimichi Kan","raw_affiliation_strings":["Department of Surgery, Hiei Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, Hiei Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Katsuya Kuwata","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katsuya Kuwata","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109550767","display_name":"Keiichi Mise","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiichi Mise","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042574372","display_name":"Hiroshi Kodama","orcid":"https://orcid.org/0000-0002-6883-834X","observed_orcids":["https://orcid.org/0000-0002-6883-834X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroshi Kodama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1993,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.54727733,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"37","issue":"7","first_page":"1259","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.027499999850988388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.746999979019165},{"id":"https://openalex.org/keywords/taxane-based-chemotherapy","display_name":"taxane-based chemotherapy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/5-dfur","display_name":"5'-DFUR","score":0.777999997138977},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.7239999771118164},{"id":"https://openalex.org/keywords/leucovorin","display_name":"leucovorin","score":0.7319999933242798},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.7210000157356262},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8259999752044678},{"id":"https://openalex.org/keywords/treatment-response-rate","display_name":"treatment response rate","score":0.6179999709129333},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8231439590454102},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7565197348594666},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7558908462524414},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7541828751564026},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6910275816917419},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6206178069114685},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6116064786911011},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5848538875579834},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5126635432243347},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4194547235965729},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.37892401218414307},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3630296587944031}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:20647706","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20647706","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},{"id":"mag:133168192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20647706","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2767596067","https://openalex.org/W2004908278","https://openalex.org/W2231583044","https://openalex.org/W2796736661","https://openalex.org/W2135601011","https://openalex.org/W2282605364","https://openalex.org/W2064845103","https://openalex.org/W2361449097","https://openalex.org/W2308070604","https://openalex.org/W2333519504"],"abstract_inverted_index":{"The":[0,50],"so-called":[1],"triple-negative":[2],"(TN)":[3],"metastatic":[4],"breast":[5],"cancer":[6],"(MBC),":[7],"that":[8,96,165],"is,":[9],"MBC":[10,37],"expressing":[11],"no":[12],"hormone":[13],"receptors":[14],"or":[15,108,143,188],"HER2":[16],"protein,":[17],"has":[18],"attracted":[19],"attention":[20],"because":[21],"of":[22,55,65,86,103,113,126,156,168,229],"its":[23],"low":[24,123,132],"response":[25,101,110,124,133,151],"rate":[26,102,125,152],"to":[27,88],"drug":[28,186],"therapy":[29,158,170,205,220],"and":[30,43,72,79,162,164,174,199,224],"poor":[31],"prognosis":[32],"after":[33,44],"recurrence.":[34],"Of":[35,145],"423":[36],"patients":[38,57,76,94],"in":[39,42,91,111,136,196,210,218],"our":[40],"hospital":[41],"2001,":[45],"54":[46,92],"had":[47],"TN":[48,56],"tumors.":[49],"median":[51],"survival":[52],"time":[53],"(MST)":[54],"(25":[58],"months)":[59],"was":[60,134,190],"shorter":[61],"than":[62],"the":[63,149,184,211,227],"MSTs":[64],"HR":[66,69,73],"(+)/HER2":[67,70],"(-),":[68],"(+),":[71],"(-)/HER2":[74],"(+)":[75],"(69,":[77],"58,":[78],"39":[80],"months,":[81],"respectively).":[82],"A":[83,130],"retrospective":[84],"analysis":[85],"responses":[87],"162":[89],"regimens":[90,98],"TN-MBC":[93,230],"showed":[95],"anthracycline":[97],"produced":[99],"a":[100,117,121,207],"18.":[104],"8%":[105],"(a":[106],"PR":[107],"higher":[109],"3":[112,197],"16":[114],"patients),":[115],"whereas":[116],"taxane":[118],"regimen":[119],"yielded":[120],"very":[122],"8.":[127],"1%":[128],"(3/37).":[129],"similar":[131],"observed":[135],"monotherapy":[137],"with":[138,193,203],"MTX,":[139],"CPT-11,":[140],"VNR,":[141],"gemcitabine,":[142],"S-1.":[144],"particular":[146],"note":[147],"were":[148,178],"high":[150],"(46.":[153],"2%,":[154],"12/26)":[155],"DMpC":[157,223],"(oral":[159],"5'-DFUR,":[160],"MPA,":[161],"CPA)":[163],"(28%,":[166],"7/25)":[167],"MFL-P":[169,225],"(MTX,":[171],"5-FU,":[172],"leucovorin,":[173],"CDDP),":[175],"although":[176],"these":[177],"not":[179],"standard":[180],"therapies.":[181],"In":[182],"addition,":[183],"molecular-targeted":[185,219],"bevacizumab":[187],"cetuximab":[189],"concomitantly":[191],"used":[192],"chemotherapeutic":[194],"agents":[195],"patients,":[198],"1":[200],"each":[201],"treated":[202],"either":[204],"achieved":[206],"PR.":[208],"Thus,":[209],"future,":[212],"we":[213],"can":[214],"expect":[215],"further":[216],"advances":[217],"while":[221],"using":[222],"for":[226],"treatment":[228],"as":[231],"an":[232],"early-line":[233],"therapy.":[234]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}